Lilly Announces Agreement to Acquire Dermira
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Dermira (DERM) Trades Above Deal Price on Speculation of Higher Bid
January 10, 2020 9:45 AM ESTDermira (NASDAQ: DERM) is trading above the Eli Lilly (NYSE: LLY) deal price of $18.75 on speculation of a higher bid. Shares last traded at $19.31. Traders note there was no deal premium, no deal leaks, although shares ramped higher... More
